Caresyntax Corp., which offers an AI-powered, vendor-neutral platform integrating data from pre-planning to post-op surgery, secured $180m in a series C extension and debt financing round.
Surgical.ai participated in the funding round with a combined undisclosed eight-figure investment
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?